Deutsche Märkte öffnen in 8 Stunden 17 Minuten

Smith & Nephew plc (SN.L)

LSE - LSE Verzögerter Preis. Währung in GBp (0.01 GBP)
Zur Watchlist hinzufügen
966,80+6,60 (+0,69%)
Börsenschluss: 04:39PM BST

Smith & Nephew plc

Building 5
Croxley Park Hatters Lane
Watford WD18 8YE
United Kingdom
44 1923 477 100
https://www.smith-nephew.com

Sektor(en)Healthcare
BrancheMedical Devices
Vollzeitmitarbeiter18.452

Leitende Angestellte

NameTitelZahlenAusgeübtGeburtsjahr
Dr. Deepak S. Nath Ph.D.CEO & Director3,75MN/A1972
Mr. John Terence RogersCFO & Executive DirectorN/AN/A1969
Mr. Paul ConnollyPresident of Global OperationsN/AN/A1968
Mr. Andrew SwiftVice President of Investor RelationsN/AN/AN/A
Ms. Helen BarracloughGroup General Counsel & Company SecretaryN/AN/A1979
Ms. Alison ParkesChief Compliance Officer & Compliance APACN/AN/A1972
Mr. Joe MetzgerSenior Vice President of Marketing Services & CommunicationsN/AN/AN/A
Mr. Philip G. CowdyChief Corporate Development & Corporate Affairs OfficerN/AN/A1967
Ms. Elga LohlerChief Human Resources OfficerN/AN/A1968
Dr. Vasant Padmanabhan Ph.D.President of Research & Development and Ear, Nose & ThroatN/AN/A1967
Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in GBp.

Beschreibung

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

Corporate Governance

Smith & Nephew plcs ISS Governance QualityScore, Stand 1. April 2024, lautet 4. Die grundlegenden Scores sind Audit: 8, Vorstand: 2, Shareholderrechte: 1, Kompensation: 7.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.